董文南, 柴尧, 刘睿, 程建明, 吴皓. 四角蛤蜊粗多糖对四氧嘧啶诱导ICR小鼠糖尿病模型的降血糖作用[J]. 南京中医药大学学报, 2015, 31(2): 134-137.
引用本文: 董文南, 柴尧, 刘睿, 程建明, 吴皓. 四角蛤蜊粗多糖对四氧嘧啶诱导ICR小鼠糖尿病模型的降血糖作用[J]. 南京中医药大学学报, 2015, 31(2): 134-137.
DONG Wen-nan, CHAI Yao, LIU Rui, CHENG Jian-ming, WU Hao. The Anti-hyperglycemic Activity of Crude Polysaccharides from Mactra Veneriformis in Alloxan Induced Diabetes in Mice[J]. Journal of Nanjing University of traditional Chinese Medicine, 2015, 31(2): 134-137.
Citation: DONG Wen-nan, CHAI Yao, LIU Rui, CHENG Jian-ming, WU Hao. The Anti-hyperglycemic Activity of Crude Polysaccharides from Mactra Veneriformis in Alloxan Induced Diabetes in Mice[J]. Journal of Nanjing University of traditional Chinese Medicine, 2015, 31(2): 134-137.

四角蛤蜊粗多糖对四氧嘧啶诱导ICR小鼠糖尿病模型的降血糖作用

The Anti-hyperglycemic Activity of Crude Polysaccharides from Mactra Veneriformis in Alloxan Induced Diabetes in Mice

  • 摘要: 目的 研究四角蛤蜊粗多糖中具有降血糖作用的活性部位。方法 ICR小鼠,尾静脉注射四氧嘧啶(80 mg/kg)生理盐水溶液,96 h后筛选空腹血糖值≥11.1 mmol/L的糖尿病小鼠。四角蛤蜊粗多糖1按200、400、800、1 200 mg/kg剂量进行分组。分别测定第7、14天的空腹血糖值,糖化血清蛋白、总胆固醇及甘油三酯含量等指标。另取糖尿病小鼠,按照筛选出四角蛤蜊粗多糖1的最佳剂量(800 mg/kg),将四角蛤蜊粗多糖1按醇沉范围分段,相同生药量换算剂量,分为四角蛤蜊粗多糖2、3组。测定四角蛤蜊粗多糖1组(800 mg/kg)、四角蛤蜊粗多糖2组(180、360 mg/kg)和四角蛤蜊粗多糖3组(2 040 mg/kg)给药第7天空腹体质量和血糖水平。结果 四角蛤蜊粗多糖1具有降血糖作用,可降低小鼠糖化血清蛋白、总胆固醇及甘油三酯含量,其中四角蛤蜊粗多糖2(180、360 mg/kg)具有降血糖作用,四角蛤蜊粗多糖3无降血糖作用。结论 四角蛤蜊粗多糖1具有降血糖作用,最佳剂量为800 mg/kg,其降糖活性部位集中于四角蛤蜊粗多糖2。

     

    Abstract: OBJECTIVE To study the anti-hyperglycemic effective sites of crude polysaccharides from Mactra veneriformis (MVPS). METHODS  Hyperglycemia models were established by intravenous injection of alloxan via tail vein of ICR mice under a dose of 80 mg/kg. After 96 h, mice with fasting blood glucose levels≥11.1 mmol/L were chosen and divided into groups. MVPS 1 treated at the doses of 200, 400, 800 mg/kg and 1 200 mg/kg once daily, respectively. At 7th and 14th days, respectively, the levels of blood glucose, GSP, TCH and TG were measured. Other diabetic mice were divided into MVPS 1 (800 mg/kg), MVPS 2 (180, 360 mg/kg) and MVPS 3 (2 040 mg/kg) groups. After 7 d treatment, both body weights and fasting blood glucose levels were measured. RESULTS MVPS 1 of 800 mg/kg displayed the optimal anti-hyperglycemic effect on diabetic mice and reduced GSP, TCH and TG levels of diabetic mice; MVPS 2 showed significantly anti-hyperglycemic activities, compared to the model group. MVPS 3 exhibited no anti-hyperglycemic activities. CONCLUSION MVPS 1 displays the optimal hypoglycemic effect at the dose of 800 mg/kg, and its hypoglycemic active site focuses on MVPS 2.

     

/

返回文章
返回